Delivery Order SPE2DB24D9134-SPE2DB25FZCP9
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $38,811.00 by the Defense Logistics Agency on September 8, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 Unit Vials valued at $12,937.00 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is issued under the company's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $64.7K with an ultimate completion date of September 18, 2025, carries no set-aside designation. The award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. The award was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, leveraging DMS Pharmaceutical Group's established position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, valued at $6,468.50 with completion targeted for September 9, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award carries no set-aside...
- The Defense Logistics Agency has awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $3,700.56 for Botox 100 unit vials. The award, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB...
- SPE2DB24D9134Indefinite Delivery Contract
- SPE2DB24D9134-SPE2DB25FZCP9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Botox 200-unit vials. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive positioning in federal procurement despite its small business status. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The company's SPE2DB indefinite delivery vehicle with DLA enables the issuance of firm fixed-price orders for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities nationwide. The Botox procurement fulfills medical supply requirements typical of the DLA's pharmaceutical distribution mission to support defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/11/25 |